Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Commentary: Successful treatme...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Commentary: Successful treatment of refractory palmoplantar pustular psoriasis with apremilast: a case series

Commentary: Successful treatment of refractory palmoplantar pustular psoriasis with apremilast: a case series

Bibliographic Details
Main Authors: Madison Hackley, Amanda Loesch, Nicholas Brownstone, Sylvia Hsu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Medicine
Subjects:
palmoplantar pustular psoriasis (PPP)
apremilast
psoriasis
psoriatic arthritis
palmoplantar psoriasis
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1283313/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1283313/full

Similar Items

  • Successful Treatment of Refractory Palmoplantar Pustular Psoriasis With Apremilast: A Case Series
    by: Sascha Ständer, et al.
    Published: (2020-10-01)
  • Natalizumab-Induced Pustular Psoriasis of Palms and Soles
    by: Bengisu Ozarslan, et al.
    Published: (2022-05-01)
  • Pustular Psoriasis: From Pathophysiology to Treatment
    by: Giovanni Genovese, et al.
    Published: (2021-11-01)
  • Risankizumab for the Treatment of Palmoplantar Pustular Psoriasis: A Report of Two Cases
    by: Luigi Gargiulo, et al.
    Published: (2023-04-01)
  • Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study
    by: A. David Burden, et al.
    Published: (2023-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs